Rapid changes in chromatin structure during dedifferentiation of primary hepatocytes in vitro
Open accessPublished version of a preprint
Abstract
Primary hepatocytes are widely used in the pharmaceutical industry to screen drug candidates for hepatotoxicity, but hepatocytes quickly dedifferentiate and lose their mature metabolic function in culture. Attempts have been made to better recapitulate the in vivo liver environment in culture, but the full spectrum of signals required to maintain hepatocyte function ex vivo remains elusive. To elucidate molecular changes that accompany, and may contribute to dedifferentiation of hepatocytes ex vivo, we performed lineage tracing and comprehensive profiling of alterations in their gene expression profiles and chromatin landscape during culture. First, using genetically tagged hepatocytes we demonstrate that expression of the fetal gene alpha-fetoprotein in cultured hepatocytes comes from cells that previously expressed the mature gene albumin, and not from a population of albumin-negative precursor cells, proving mature hepatocytes undergo true dedifferentiation in culture. Next we studied the dedifferentiation process in detail through bulk RNA-sequencing of hepatocytes cultured over an extended period. We identified three distinct phases of dedifferentiation: an early phase, where mature hepatocyte genes are rapidly downregulated in a matter of hours; a middle phase, where fetal genes are activated; and a late phase, where initially rare contaminating non-parenchymal cells proliferate, taking over the culture. Lastly, to better understand the signaling events that result in the rapid downregulation of mature genes in hepatocytes, we examined changes in chromatin accessibility in these cells during the first 24 h of culture using Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq). We find that drastic and rapid changes in chromatin accessibility occur immediately upon the start of culture. Using binding motif analysis of the areas of open chromatin sharing similar temporal profiles, we identify several candidate transcription factors potentially involved in the dedifferentiation of primary hepatocytes in culture.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
T3 treatment does not prevent the loss of Hep-ID TF gene expression that occurs spontaneously when primary mouse hepatocytes are cultured in vitro.
“We could not however observe any protective role for T3 treatment with regards to the loss of Hep‐ID TF gene expression spontaneously occurring when primary mouse hepatocytes (MPH) are cultured in vitro (Ploton et al, 2018; Seirup et al, 2022; Appendix Fig S14).”
From An extended transcription factor regulatory network controls hepatocyte identity (2023) · cites this paper as Seirup et al, 2022
The Results (section 2.2) report that mature hepatocyte marker genes decline during culture, and the Methods (section 4.2) identify the hepatocytes as mouse-derived. The paper does not report T3 treatment or establish that T3 fails to prevent loss of Hep-ID transcription-factor gene expression; that treatment result is presented as the citing authors’ own observation. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMPH dedifferentiation is most probably linked to immediate and simultaneous drastic changes, including chromatin structure changes, that make this dedifferentiation model inherently difficult to intervene with.
“This is most probably linked to the immediate and simultaneous drastic changes occurring in MPH, including at the chromatin structure level, which characterize this dedifferentiation model and make it inherently difficult to intervene with (Seirup et al, 2022).”
From An extended transcription factor regulatory network controls hepatocyte identity (2023) · cites this paper as Seirup et al, 2022
The Abstract and Discussion report rapid chromatin-accessibility and gene-expression changes in cultured primary hepatocytes. The Introduction says existing culture techniques have not completely maintained the mature phenotype. The paper does not establish that simultaneous changes make dedifferentiation inherently difficult to intervene with; its Discussion describes the process in phases. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · see citing works
Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327 · see citing works
Drug Safety Sciences and the Bottleneck in Drug Development
Watkins, P. B. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.63 · Cited by 211 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
An extended transcription factor regulatory network controls hepatocyte identity
Dubois‐Chevalier, J., Gheeraert, C., Berthier, A., Boulet, C., Dubois, V., Guille, L., Fourcot, M., Marot, G., Gauthier, K., Dubuquoy, L., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357020 · Cited by 6 · see citing works
- Authors
- Seirup, M., Sengupta, S., Swanson, S., McIntosh, B. E., Collins, M., Chu, L.-F., Cheng, Z., Gorkin, D. U., Duffin, B., Bolin, J. M., Argus, C., Stewart, R., & Thomson, J. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Morgridge Institute for Research (US)
- LabCorp (United States) (US)
- University of California San Diego (US)
- Corresponding author
- Seirup, Morten
- Sengupta, Srikumar
- Thomson, James A.
- ORCID
- Venue
- Genomics
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 114
- Issue
- 3
- Pages
- 110330
- ISSN
- 0888-7543 (ISSN-L)
- OpenAlex
- W4220821957
- Cited by
- 13
- References
- 3
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genomics (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- hepatocyte dedifferentiation, primary hepatocytes, chromatin accessibility, alpha-fetoprotein, albumin, gene expression profiling, transcription factor binding motifs, hepatocyte culture, hepatotoxicity screening
- MeSH terms
- Albumins, Cells, Cultured, Chromatin, Liver, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review